пятница, 27 мая 2016 г.

Ionis Slumps, Rival Alnylam Soars as GSK Decides Against Trial

Ionis Slumps, Rival Alnylam Soars as GSK Decides Against Trial


Ionis Pharmaceuticals Inc. plunged the most since 2003 after GlaxoSmithKline Plc decided not to test a drug the companies were developing together. Alnylam Pharmaceuticals Inc., which is developing a rival therapy, soared on the news.



from Biotech News